Repositório Institucional da ENAP
metadata only
The landscape for vaccine candidates of COVID-19: is there any relationship between innovation and the business environment of countries?
The insurgency of the new coronavirus (SARS-COV-2) has attracted the attention of the public, authorities and academics. To date, no chemical treatment has proven efficient in clinical tests to combat the virus. The hope for the reopening of socioeconomic activities is found in the discovery of v
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)#914321
- Vienna Versus SARS-CoV-2 Virus Study#875352
- Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine#867881
- COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older#290850
- SARS-CoV-2/COVID-19 Prevalence Study#1138510
Record · ID 962232
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive